EQT to Acquire Qiagen in €10.8 Billion Deal

Paul, Weiss is advising EQT XI fund on the financing aspects of the all-cash voluntary public takeover offer for all outstanding shares in Qiagen N.V., a global leader in in life science tools and molecular diagnostics. Under the agreement, Qiagen is valued at approximately €10.8 billion, marking one of the largest take-private transactions this year. EQT is investing alongside co-investors the Abu Dhabi Investment Authority and the Canada Pension Plan Investment Board.
 
The Paul, Weiss team is led by Taner Hassan, Deirdre Jones and Matthew Merkle, and includes partners Suhan Shim and DongHwa Kim.